Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 150 /hr

★★★★★

☆☆☆☆☆

Hire Jing H.

United States

USD 150 /hr

Principal Scientist, AI Drug Design, Antibody Engineering, HIS Mouse Expert, 22 Yrs RnD

Profile Summary

PhD scientist (Chinese Academy of Sciences) with 22 years RnD in immunology, antibody engineering, and AI drug design. Founder of InSynBio (AI antibody platform) and NextVivo/Genomab (35 humanized immune system mouse strains, 8 patents). 13 years at Aaron Diamond AIDS Research Center, Rockefeller University and Columbia University. 30 SCI publications. Services: antibody and CAR-T consulting, AI drug design, scientific writing (papers, reviews, SOPs), science website development.

Subject Matter Expertise

• ☆ Microbiology
• ☆ Artificial Intelligence
• ☆ Biomolecular Engineering
• ☆ Antibody Engineering
• ☆ Gene Delivery
• ☆ Drug Development
• ☆ In vivo Preclinical Toxicology
• ☆ Oncology
• ☆ Immunotherapy
• ☆ Software Development
• ☆ Web Application Development

Services

• Writing
• Research
• Consulting

Writing Medical Writing, Technical Writing

Research Feasibility Study, Technology Scouting, Scientific and Technical Research

Consulting Healthcare Consulting, Scientific and Technical Consulting

Work Experience

Principle Scientist, AI-based Drug design

InSynBio.com

January 2026 - Present

Website developer

USLifeHub.org

January 2026 - Present

Principle Scientist

Genomab Biotech

January 2020 - Present

ADARC

July 2008 - Present

Education

PhD. (institute of zoology)

Chinese Academy of Sciences

September 1998 - August 2003

Exchange Scholar

Danish Pest Infestation Laboratory, Denmark

June 2002 - May 2003

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Jing Huang, Timothy W. Phares, Vinayaka Kotraiah, Mary J. Hauser, Arban Domi, Sreenivasa Oruganti, Cecille D. Browne, Peter Buontempo, Marc Mansour, James Pannucci, et al. (2022). Viral delivery of a peptide-based immunomodulator enhances T cell priming during vaccination . Frontiers in Pharmacology.

Huang J, Zhou J, Ghinnagow R, Seki T, Iketani S, Soulard D, Paczkowski P, Tsuji Y, MacKay S, Cruz LJ, et al. (2020). Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141⁺ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8⁺ T Cell Response in Human Immune System Mice . Frontiers in immunology.

Jing Huang, Tiffany Tsao, Min Zhang, Urvashi Rai, Moriya Tsuji, Xiangming Li (2015). A sufficient role of MHC class I molecules on hepatocytes in anti-plasmodial activity of CD8+ T cells in vivo . Frontiers in Microbiology.

Jing Huang, Xiangming Li, Jordana G. A. Coelho-dos-Reis, James M. Wilson, Moriya Tsuji (2014). An AAV Vector-Mediated Gene Delivery Approach Facilitates Reconstitution of Functional Human CD8+ T Cells in Mice . PLoS ONE.

Jing Huang, Cagdas Tazearslan, Nir Barzilai, Yousin Suh (2011). Impaired IGF1R signaling in cells expressing longevity-associated human IGF1R alleles . Aging Cell.